What is Aptevo Therapeutics Inc?
, a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.40M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.